Navigation Links
CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation
Date:6/1/2010

SAN DIEGO, June 1 /PRNewswire-FirstCall/ -- CareFusion (NYSE: CFN), a leading, global medical device company today announced the launch of its Closed Loop Controller of Inspired Oxygen system or "CLiO2™," the first automatic oxygen controller of its kind designed to keep the oxygen level in the blood within a safe range for newborns needing mechanical ventilation. This new software algorithm is an enhancement to the CareFusion AVEA™ ventilator, one of the leading ventilators in the world.  

"Traditionally, newborns' ventilation and oxygen levels are constantly monitored and adjusted by the hospital staff," said Dr. Sithembiso Velaphi, MBChB, FCPaeds head of the division of Neonatology at Chris Hani Baragwanath Hospital in Soweto, Johannesburg, South Africa. "By automating this process, the CLiO2 system has allowed us to give better care more easily and safely to these newborns."

The CLiO2 system noninvasively and continuously measures the oxygen level in a newborn's blood using Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry technology to provide accurate and reliable oxygen saturation (SpO2) measurements, even under challenging clinical conditions. The CLiO2 system processes blood oxygen saturation levels by a computer algorithm that then anticipates trends and modifies the amount of oxygen delivered. If necessary, adjustments can be made on a second to second basis, something not currently possible with manual control.

"If oxygen levels become either too high or too low for premature babies on ventilation they are at risk for serious complications, such as permanent eye or chronic lung damage," said Dr. Steven M. Donn, professor of Pediatrics in the Division of Neonatal-Perinatal Medicine at the University of Michigan Health System. "I have been very impressed with how much more stable oxygen levels become with the CLiO2 system compared to what we've used in the past."

"We built the CLiO2 system to address a worldwide medical need to improve the way newborns are cared for in hospitals," said David Schlotterbeck, chairman and CEO at CareFusion. "We hope this system will help reduce complications associated with newborns needing mechanical ventilation and can free up time for clinicians to better care for some of their most vulnerable patients."    

The CLiO2 system is currently available in most Western Europe and Asian countries through CareFusion and its authorized distributors, with future availability in the U.S. and Canada.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined™ services for infection surveillance, NeuroCare neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.


'/>"/>
SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Completes Medegen Acquisition
2. CareFusion Announces Agreement With Banner Health to Upgrade and Extend Pyxis Medication Solutions
3. CareFusion, Cerner to Integrate Technologies for Improved Hospital Safety, Efficiency
4. CareFusion Will Host an Earnings Conference Call on May 6 to Discuss the Results for the Third Quarter of Fiscal 2010
5. CareFusion Launches New Pyxis ProcedureStation(TM) Radio Frequency Identification System at Association of Perioperative Registered Nurses 57th Annual Congress
6. CareFusion Sponsors Global Summit of Patient Safety Leaders
7. CareFusion Reports Second Quarter Results
8. CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health
9. CareFusion Signs Exclusive Partnership Agreement With Minimally Invasive Devices to Distribute FloShield Laparoscopic Technology
10. CareFusion Will Host an Earnings Conference Call on Feb. 9 to Discuss the Results for the Second Quarter of Fiscal 2010
11. FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology:
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):